Pharm D. Hina Jolin

Hina Jolin, Pharm D., has a diverse work experience in the pharmaceutical industry. Hina is currently serving as the Director of Clinical Science at Cogent Biosciences since March 2021. Previously, from 2019 to 2021, they worked as an Associate Director of Clinical Science at Syros Pharmaceuticals.

Prior to that, Hina held various roles at Takeda Oncology from 2015 to 2019, including Associate Director of Clinical Science, Senior Clinical Scientist, and Clinical Scientist. In these positions, they contributed to the clinical development of a global oncology trial and was involved in protocol management, data analysis, and regulatory submissions.

Before entering the pharmaceutical industry, Hina gained experience in clinical research as a CCTO Clinical Research Pharmacist at Beth Israel Deaconess Medical Center from 2013 to 2015. Hina also worked as a Clinical Oncology Research Pharmacist at the same institution from 2012 to 2015.

Additionally, Hina has teaching experience as an Adjunct Professor at the Massachusetts College of Pharmacy and Allied Health Sciences from 2007 to 2014.

Earlier in their career, Hina held roles as a Senior Clinical Research Pharmacist at Brigham and Women's Hospital from 2006 to 2012 and as a Staff Pharmacist at Dana Farber Cancer Institute from 2009 to 2012.

Hina started their career as a Pharmacist at CVS Pharmacy, where they worked from 2000 to 2011.

Overall, Hina Jolin has extensive expertise and knowledge in clinical science, clinical research, and pharmacy practice, making their a valuable asset in the pharmaceutical industry.

Hina Jolin, Pharm D. began their education in 1998 at Boston University, where they studied English for two years. In 2000, they transferred to the Massachusetts College of Pharmacy and Health Sciences, where they completed their Doctor of Pharmacy (Pharm.D.) degree in 2005, specializing in Pharmacy.